Neuroimaging Market Growth Accelerated by Adoption of Novel Imaging Techniques
Neuroimaging
is a technique used to capture images of the brain and the central nervous
system with the help of techniques such as computed tomography (CT), magnetic
resonance imaging (MRI), positron emission tomography (PET), and functional
magnetic resonance imaging (fMRI). Neuroimaging techniques play a vital role in
the diagnosis and treatment of various neurological disorders such as
Parkinson's disease, Alzheimer's disease, stroke, and traumatic brain injuries.
The
global Neuroimaging Market is estimated to be valued at US$ 6.3 billion in 2023
and is expected to exhibit a CAGR of 18.% over the forecast period 2024 to
2028, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The
adoption of novel neuroimaging techniques such as high-field MRI,
ultra-high-field MRI, functional MRI (fMRI), positron emission tomography
scanners (PET), multi-modality imaging systems integrating CT and MRI with PET
scanner, and functional near-infrared spectroscopy (fNIRS) have accelerated
market growth over the forecast period. High-field MRI and ultra-high-field MRI
systems provide high-resolution images that help clinicians efficiently
diagnose various neurological conditions. The integration of PET and CT/MRI
modalities provides both anatomical and functional information, thereby better
understanding of disease progression. With increasing applications of neuroimaging
in pre-clinical drug development studies and the introduction of portable fNIRS
devices, the neuroimaging market is expected to witness significant growth
during the forecast period.
Segment Analysis
The Global Neuroimaging Market
Size is segmented based on product type, application, end users,
and geography. By product type, the MRI systems segment dominates the market as
it provides high-quality images of the brain and spinal cord and is extensively
used for diagnosing brain disorders and neurological complications. It allows
doctors to accurately diagnose brain tumors, stroke, epilepsy, head injuries
and other neurological conditions.
By application, the neurological segment holds the largest share of the market
owing to the high usage of neuroimaging systems like MRI and CT for diagnosing
neurological conditions. Neuroimaging helps in early detection, monitoring
progression, evaluating treatment impact of conditions like Parkinson's
disease, Alzheimer's disease, epilepsy and stroke.
Key Takeaways
The
global neuroimaging market is expected to witness high growth over the forecast
period of 2024 to 2030.
Regional
analysis: North America currently holds the largest share of the global
neuroimaging market due to factors like rising neurological disorders
incidence, advanced healthcare infrastructure and availability of
reimbursement. The Asia Pacific region is witnessing highest growth and is
projected to grow at over 20% CAGR during the forecast period driven by growing
geriatric population, improving healthcare spending and increasing awareness.
Key players: Key players operating in the neuroimaging market are General
Electric Company, Siemens Healthineers, Canon Medical Systems Corporation,
Fujifilm Holdings Corporation, Koninklijke Philips N.V., Aspect Imaging,
Bruker, Hitachi Ltd, Esaote SpA and Mindray Medical International. General
Electric dominates the market with its wide MRI product portfolio and global
presence. Other major players are focusing on developing next generation
multi-modality systems and expanding into emerging Asian markets.
Get More Insights On This Topic: https://www.ukwebwire.com/neuroimaging-market-size-share-analysis-2023-2030/
Explore More Trending Article On This Topic: https://masstamilan.tv/understanding-the-human-microbiome/
Comments
Post a Comment